Howard Hughes Medical Institute’s Alibaba BABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,596
Closed -$172K 160
2017
Q1
$172K Sell
1,596
-20
-1% -$2.04K 0.03% 121
2016
Q4
$142K Sell
1,616
-4,269
-73% -$411K 0.03% 125
2016
Q3
$623K Buy
5,885
+3,786
+180% +$351K 0.16% 85
2016
Q2
$167K Sell
2,099
-210
-9% -$16.4K 0.06% 123
2016
Q1
$182K Sell
2,309
-988
-30% -$69.5K 0.04% 115
2015
Q4
$268K Sell
3,297
-4,982
-60% -$391K 0.04% 122
2015
Q3
$488K Sell
8,279
-2,038
-20% -$148K 0.09% 97
2015
Q2
$849K Buy
10,317
+4,187
+68% +$360K 0.18% 80
2015
Q1
$510K Sell
6,130
-5,381
-47% -$486K 0.07% 96
2014
Q4
$1.2M Buy
+11,511
New +$1.18M 0.32% 57

Other funds holding BABA

Howard Hughes Medical Institute's BABA Position: Q2 2017 in Review

Howard Hughes Medical Institute sold out of Alibaba (BABA) in Q2 2017, closing a stake of 1,596 shares — an estimated $172K sold.

Howard Hughes Medical Institute first reported a position in BABA in Q4 2014 and held it in 10 quarters. The position peaked at $1.2M in Q4 2014. 977 funds tracked by Wall St. Rank hold BABA as of Q2 2017.

  • Howard Hughes Medical Institute reported no remaining Alibaba position as of Q2 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 1,596 Alibaba shares in Q2 2017, an estimated $172K.
  • Howard Hughes Medical Institute first reported a position in Alibaba in Q4 2014 and held it in 10 quarters.
  • Howard Hughes Medical Institute's Alibaba position peaked at $1.2M in Q4 2014.
  • 977 funds tracked by Wall St. Rank held Alibaba as of Q2 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2017, filed 11 Aug 2017.